05 Compliance

Where bone collagen peptides are permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-19 · Bone Collagen Peptides

On this page
  1. The four checks
  2. European Union
  3. United States
  4. United Kingdom
  5. The contaminant limits
  6. Claims and label boundaries
  7. The document pack
  8. What to check before the first order

Bovine bone collagen peptides are a food ingredient and a food supplement ingredient in the EU, the US and the UK. In all three markets the permission question is usually settled quickly; the file is what takes the time — the species and tissue declaration, the TSE statement that follows bone, the contaminant results and the label wording. The notes below are as of this review and should be checked against the current text before a launch.

In one line

Bone collagen peptides are a food ingredient in the EU, the US and the UK; the source, the TSE file, the contaminant panel and the label carry the compliance weight.

The four checks

Compliance is four questions, usually answered in this order: is the ingredient permitted in the market and the category; is the source acceptable, which for bone means the TSE file; are the contaminants inside the limits; does the label and any claim match the file? A positive answer to the first does not carry the other three.

The category matters as much as the ingredient. A collagen peptide sold as a food supplement follows the supplement rules in the EU and the UK and the dietary supplement rules in the US; the same powder sold as a food or beverage follows the general food rules. The ingredient file is similar; the label rules are not.

European Union

Collagen hydrolysate has a documented history of use as a food ingredient before 15 May 1997, which is the reference date in the novel food Regulation (EU) 2015/2283. On that basis it is regarded as a food ingredient rather than a novel food, and the novel food catalogue should be checked before a new market is entered. Food supplements sit under Directive 2002/46/EC, general food law under Regulation (EC) No 178/2002, labelling under Regulation (EU) No 1169/2011, and claims under Regulation (EC) No 1924/2006.

Bone is the part of the file that needs attention. The TSE Regulation (EC) No 999/2001 controls the raw material, the specified risk material and the processing conditions, and a bone-derived lot should travel with a declaration that names the species, the tissue, the origin and the site. Contaminants are set by Regulation (EU) 2023/915 as of this review; check the consolidated text, because the annexes are amended.

United States

In the US, collagen peptides are a dietary ingredient under the Dietary Supplement Health and Education Act, with the label and facility obligations in 21 CFR 101 and the preventive-controls rules. The ingredient needs no pre-market approval, but the seller is responsible for identity, purity and labelling.

For cattle-derived material, the FDA guidance on the use of materials derived from cattle in human food and cosmetics is the reference for the BSE controls, and the supplier declaration should show that the material complies. Contaminant limits are not harmonised at federal level: lead, arsenic, cadmium and mercury are addressed through FDA action levels, and California's Proposition 65 adds a separate exposure route for products sold into that state. A specification built to the EU limits is a practical starting point for the US file, not a substitute for the state-level review.

United Kingdom

The UK applies retained food information rules, the Food Safety Act 1990 and the Food Information Regulations 2014 in England, with devolved equivalents elsewhere, and the FSA is responsible for novel food assessment. TSE controls are retained in UK law and mirror the EU Regulation in structure. Great Britain and Northern Ireland have diverged in some areas since 2021, so the market should be named on the file: a label accepted in London is not automatically accepted in Belfast, and the reverse.

The bone source is the item that draws the questions: the TSE declaration, the species and tissue statement and the origin should be issued for the lot, not for the supplier in general.

The contaminant limits

Contaminant limits · EU food supplements and the catalogue specification
ParameterEU limit (food supplements)Catalogue limit
Lead3.0 mg/kg≤3 mg/kg
Cadmium1.0 mg/kg≤1 mg/kg
Mercury0.1 mg/kg≤0.1 mg/kg
ArsenicNo harmonised limit≤2 mg/kg
APC—≤1,000 cfu/g
Yeast and mould—≤100 cfu/g
E. coli—Absent
Salmonella—Absent

The EU does not set a harmonised arsenic limit for food supplements, so the 2 mg/kg line is a customer specification rather than a legal one. The microbiological lines are commercial limits agreed in the specification, not a harmonised EU criterion for collagen peptides. The legal baseline is that the food must be safe, and the buyer's specification is how that baseline is demonstrated lot by lot.

Claims and label boundaries

No disease-related claim can be made for the peptide. In the EU and the UK, a health claim has to come from the authorised list in Regulation (EC) No 1924/2006 as retained, and the claims that mention collagen in that list belong to vitamins and minerals, not to collagen peptides. A collagen product cannot borrow a vitamin claim unless the vitamin is present in the quantity the claim requires.

In the US, a structure or function statement is allowed without pre-approval, but it must be truthful, not misleading, and accompanied by the DSHEA disclaimer. The safer label describes the ingredient and its composition — bovine bone collagen peptides, protein per serving, hydroxyproline — and leaves the outcome to the consumer. The identity page sets out what the file can prove about composition.

The document pack

Documents that travel with a bone collagen lot
DocumentWhat it shows
SpecificationProtein factor and basis, hydroxyproline, SEC, ash, mesh
COALot results against the specification, with methods
TDSHandling, solubility, storage and pack
SDSHazard classification for transport and handling
BSE/TSE declarationSpecies, tissue, origin, site and processing controls
Species and tissue statementBovine, bone, country of origin
Allergen statementBovine material; no declared allergen in the peptide itself
Site certificateGMP, HACCP or an equivalent food-safety scheme

Halal or kosher certificates, when the market asks for them, are issued for the site and the process and have to be current. They sit on top of the pack above, not instead of it.

What to check before the first order

  • Ingredient status confirmed for each market, and for the product category.
  • Species and tissue named on the specification, the COA and the label.
  • BSE/TSE declaration issued for the lot, the site and the origin.
  • Contaminants inside the EU limits and the customer specification.
  • Micro limits agreed and tested on every lot.
  • Label ingredient name and allergen statement match the file.
  • Claims checked against the authorised list or the DSHEA rules.
  • Document set complete, current and version-controlled.

The COA page covers the analytical lines, the grade page covers the source decision, and the EU, US and UK regulatory notes give the market framework. The product page carries the catalogue ranges.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation